#USA #Westborough #Olympus #Endocision #cryobiopsy

Olympus and Endocision: A New Era in Respiratory Care

Olympus Corporation, a leader in medical technology, recently unveiled a groundbreaking global distribution agreement with Endocision, promising to bring a state-of-the-art portable, single-use flexible cryocatheter system to medical facilities worldwide. This partnership marks a significant milestone in enhancing respiratory care through advanced medical technologies.

Transformative Technology for Bronchoscopic Procedures

The agreement, which establishes Olympus as the exclusive global distributor of the Endocision platform, allows for a seamless integration of this innovative cryocatheter into various bronchoscopic diagnostic and therapeutic procedures. Olympus and Endocision anticipate launching this highly anticipated product in key markets, including the United States, Canada, and Europe, in early 2027.

This collaboration aims to enrich Olympus’s already impressive respiratory product portfolio, which features advanced tools such as endobronchial ultrasound (EBUS), crucial for visualizing and biopsing lung tissues and lymph nodes effectively. "This partnership with Endocision underscores our commitment to enhancing our respiratory solutions that span from peripheral bronchoscopy to radial EBUS and even single-use bronchoscopes, offering optimal endoscopic options across varying clinical scenarios," commented Seiji Kuramoto, CEO of Olympus’s Surgical Solutions division.

Enhanced Portability and Functionality

One of the standout features of the new cryocatheter system is its portability; it operates without the need for electric power or large CO2 tanks, facilitating widespread adoption of cryobiopsy and cryoextraction across various healthcare environments, including bronchoscopy suites, intensive care units, operating rooms, and emergency departments. This breakthrough in cryotechnology has emerged as an essential tool in interventional pulmonology and thoracic endoscopy, aiding in both tissue acquisition and therapeutic interventions within the airways.

Wide-Ranging Clinical Applications

The cryocatheter offers a multitude of clinical applications. It is adept at performing transbronchial cryobiopsies, enabling efficient tissue sampling, as well as assisting in the removal of foreign bodies, blood clots, and mucus plugs. Moreover, it provides a means for endobronchial tumor volume reduction and the recanalization of airways, significantly enhancing patient care outcomes.

Recent studies have revealed that cryobiopsies yield larger tissue samples with less associated tissue damage compared to conventional forceps biopsies, reducing compression artifacts and potentially improving histopathological and molecular analyses.

Dr. Moishe Liberman, President and Chief Medical Officer of Endocision, expressed enthusiasm for this collaboration, stating, "We are excited to present the next generation of cryocatheter systems and work alongside Olympus to advance interventional pulmonology and thoracic endoscopy. The Endocision cryocatheter system is meticulously designed to support a wide array of bronchoscopic applications that enhance tissue acquisition and therapeutic interventions while increasing access to cryotechnology in diverse clinical settings."

Showcasing Innovation at the AABIP Conference

Both Olympus and Endocision are set to showcase the Endocision flexible cryocatheter system at the upcoming Annual American Association for Bronchology and Interventional Pulmonology (AABIP) conference, taking place from August 20-22 in Denver. This event will serve as a platform for the healthcare community to witness firsthand the innovative advancements in respiratory care technology resulting from this strategic alliance.

About Olympus

Olympus is steadfast in its mission to enhance the quality of life through innovative medical technology. With over a century of experience, Olympus has established itself as a global leader in the medical field, focusing on providing healthcare professionals with cutting-edge products and solutions. For more information about Olympus and its product offerings, please visit their official website and follow them on LinkedIn for updates.

About Endocision

Founded in 2019, Endocision is a Canadian medical technology company, dedicated to developing innovative, minimally invasive cryogenic devices for the treatment and diagnosis of pulmonary diseases. The company is committed to employing advanced technologies compatible with both traditional and robotic bronchoscopy platforms to enhance patient care outcomes. For details about Endocision, check out their website and LinkedIn page.

Through this partnership between Olympus and Endocision, the future of respiratory care is looking brighter than ever, with innovative solutions paving the way for improved patient outcomes and advanced medical interventions.